title: Bullous erythema multiforme after treatment with Malarone, a combination antimalarial composed of atovaquone and proguanil hydrochloride.
abstract: We report on a Kenyan woman who developed bullous erythema multiforme, in association with Malarone treatment.
authors.affiliation: United States Army Medical Research Unit-Kenya (USAMRU-K), Walter Reed Project, Kisumu, Kenya.
authors.forename: Shon A
authors.initials: SA
authors.lastname: Remich
authors.forename: Walter
authors.initials: W
authors.lastname: Otieno
authors.forename: Mark E
authors.initials: ME
authors.lastname: Polhemus
authors.forename: Bernhards
authors.initials: B
authors.lastname: Ogutu
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Walsh
mesh_terms: D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects*; D053626:Atovaquone / Q000008:administration & dosage / Q000009:adverse effects*; D004338:Drug Combinations; D004892:Erythema Multiforme / Q000209:etiology*; D005260:Female; D006801:Humans; D007630:Kenya; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D008875:Middle Aged; D002727:Proguanil / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; C109496:atovaquone, proguanil drug combination; D002727:Proguanil; D053626:Atovaquone